Global pharmaceutical and healthcare products giant, Wyeth, plans to increase its presence in Asia-Pacific by investing S$134 million (US$96 million) to expand its nutritional manufacturing facility in Singapore.

Located in Tuas, the state-of-the-art facility is managed by Wyeth Nutritionals Singapore Pte Ltd. The facility utilises the strictest of operational and quality standards in producing key Wyeth brands of nutritional products for infants and toddlers, including formula and milk products such as Progress and Promise. The extension will increase production capacity by 50 per cent, which will allow the company to increase its supply to markets in Singapore and the other Asia-Pacific countries.

"This investment reflects Wyeth's 90-year heritage of scientific innovation and commitment to pediatric nutrition," says Mark Larsen, President, Asia Pacific and Nutritionals, Wyeth Pharmaceuticals. "A key element of our company's mission is ensuring that infants and children have access to the best and highest quality products. This site will help us continue to achieve this objective."